Anti-PSCA monoclonal antibody (Agensys)

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameAnti-PSCA monoclonal antibody (Agensys)
Drug Alias Name抗PSCA单克隆抗体AGS-1C4D4MK-4721AGS-PSCA
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionProstate stem cell antigen inhibitorsImmunostimulants
TargetsProstate stem cell antigen
Therapy Area/IndicationsPancreatic DiseasesProstatic NeoplasmsPancreatic Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesRussian Federation +[5] 
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAgensys Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAstellas Pharma IncAgensys Inc
Active IndicationsN/A
Inactive IndicationsPancreatic DiseasesProstatic NeoplasmsPancreatic Neoplasms +[4] 

Other Information

ATC CodeN/A
Related LinksN/A